Table 1.
Clinical characteristics of the Discovery Cohorts used for the HuProt™ protein microarray studies. Basic clinical characteristics of all samples comprising the Discovery Cohort are provided as used for the HuProt microarray studies. The adenocarcinoma (AdCa) and squamous cell carcinoma (SqCC) samples are each divided across four sample pools, whereas the non-actionable samples are divided across two sample pools.
| Group | Actionable | Non-Actionable | ||
|---|---|---|---|---|
| AdCa | SqCC | |||
| (n = 25) | (n = 17) | (n = 20) | ||
| Age (years) | Median (Range) | 70 (56–83) | 75 (60–79) | 65 (58–71) |
| Gender | Male (%) | 13 (50%) | 8 (47.1%) | 10 (52.6%) |
| Lesion Size (mm) | Median (range) | 24.8 (11–38) | 28 (11–35) | 3 (2–10) |
| AJCC Stage | IA1 | 1 | N/A | |
| IA2 | 8 | 6 | ||
| IA3 | 4 | 7 | ||
| IB | 12 | 3 | ||
| IIB | N/A | 1 | ||